COVID-19 rapid test

flufor antigensprotein

COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B. ntroduction Multiple viral infections is a trend, and many COVID-19 patients have multiple viral infections. Coinfection in COVID-19 patients may worsen disease outcomes. We found that a higher proportion of patients with COVID-19 were coinfected with one or more additional pathogens. [ From JCLA Journal of Clinical Laboratory Analysis ] Symptoms caused by the infection of SARS-CoV-2 and Influenza viruses are very similar, which brings a huge challenge in diagnosis and timely medical treatment. Biotime Flu A/B & COVID-19 Ag Combo Test with differentiated detection of the multiple pathogens will reduce times and uncertainty on the initial screening of patients with SARS-CoV-2 or Influenza. Product specification: Sample Type: Nasal swab Loading Volume: 65uL Reaction Time: 15 min Shelf Life: 24 months Storage Condition: 2-30℃ Unit: 20 kits/box